CLINICAL_TRIALS
trial_result
· 2019-04-17
Clinical Trial Update: Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans? [Phase 4]
Summary
Phase 4 trial evaluating whether PTH 1-34 (teriparatide) enhances spinal fusion in humans with spinal stenosis has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Linkoeping | Conditions: Spinal Stenosis | Phase 4 | Status: COMPLETED